Saltar al contenido
Merck

Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance.

Acta neuropathologica (2019-12-19)
Viktoria Melcher, Monika Graf, Marta Interlandi, Natalia Moreno, Flavia W de Faria, Su Na Kim, Dennis Kastrati, Sonja Korbanka, Amelie Alfert, Joachim Gerß, Gerd Meyer Zu Hörste, Wolfgang Hartmann, Michael C Frühwald, Martin Dugas, Ulrich Schüller, Martin Hasselblatt, Thomas K Albert, Kornelius Kerl
RESUMEN

Atypical teratoid/rhabdoid tumors (ATRT) are known for their heterogeneity concerning pathophysiology and outcome. However, predictive factors within distinct subgroups still need to be uncovered. Using multiplex immunofluorescent staining and single-cell RNA sequencing we unraveled distinct compositions of the immunological tumor microenvironment (TME) across ATRT subgroups. CD68+ cells predominantly infiltrate ATRT-SHH and ATRT-MYC and are a negative prognostic factor for patients' survival. Within the murine ATRT-MYC and ATRT-SHH TME, Cd68+ macrophages are core to intercellular communication with tumor cells. In ATRT-MYC distinct tumor cell phenotypes express macrophage marker genes. These cells are involved in the acquisition of chemotherapy resistance in our relapse xenograft mouse model. In conclusion, the tumor cell-macrophage interaction contributes to ATRT-MYC heterogeneity and potentially to tumor recurrence.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Medio RPMI-1640, With L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture
Millipore
Plaquitas verticales para cultivo celular Millicell®, pore size 0.4 μm, diam. 30 mm, transparent PTFE membrane, hydrophilic, H 13 mm, size 6 wells, sterile